SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Panel Rejects New Use for Forest Laboratories, Inc. (JOBS) Heart Drug

January 12, 2010 | 
1 min read
Bookmark and Share

WASHINGTON (AP) -- Federal health advisers on Monday unanimously rejected a new use of Forest Laboratories' hypertension drug for patients at risk of heart failure.
FDA Approvals Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Oct 9, 2019 Milpitas / CA / USA - Johnson & Johnson Vision offices in Silicon Valley; Johnson & Johnson Vision Care, Inc. is part of the American multinational corporation Johnson&Johnson
Approvals
J&J Wins Expansion for Top-Selling Cancer Drug in First for Smoldering Multiple Myeloma
November 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Buying tickets. The hands of the person holding the tickets. Isolated illustration on a yellow background. Template for the design. Trending vector graphics.
Regulatory
Wegovy, Casgevy Among Latest FDA Priority Review Voucher Recipients
November 6, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Poster sketch image artwork photo collage of body language finger showing gesture symbol thumb down dislike dissatisfied minus no opinion.
FDA
FDA’s Top Cancer Regulator Declined CDER Directorship
November 6, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA
Webinar: FDA in 2025: Navigating an Uncertain Regulatory Future
November 5, 2025
 · 
1 min read
 · 
Jef Akst